chr7-152252650-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_170606.3(KMT2C):​c.1365A>G​(p.Ile455Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0357 in 1,613,196 control chromosomes in the GnomAD database, including 1,244 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I455V) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.025 ( 77 hom., cov: 32)
Exomes 𝑓: 0.037 ( 1167 hom. )

Consequence

KMT2C
NM_170606.3 missense

Scores

17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3O:1

Conservation

PhyloP100: -0.0770

Publications

14 publications found
Variant links:
Genes affected
KMT2C (HGNC:13726): (lysine methyltransferase 2C) This gene is a member of the myeloid/lymphoid or mixed-lineage leukemia (MLL) family and encodes a nuclear protein with an AT hook DNA-binding domain, a DHHC-type zinc finger, six PHD-type zinc fingers, a SET domain, a post-SET domain and a RING-type zinc finger. This protein is a member of the ASC-2/NCOA6 complex (ASCOM), which possesses histone methylation activity and is involved in transcriptional coactivation. [provided by RefSeq, Jul 2008]
KMT2C Gene-Disease associations (from GenCC):
  • Kleefstra syndrome 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Illumina, Ambry Genetics, Broad Center for Mendelian Genomics
  • syndromic intellectual disability
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0062871873).
BP6
Variant 7-152252650-T-C is Benign according to our data. Variant chr7-152252650-T-C is described in ClinVar as [Benign]. Clinvar id is 134736.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.025 (3815/152324) while in subpopulation NFE AF = 0.0401 (2726/68018). AF 95% confidence interval is 0.0388. There are 77 homozygotes in GnomAd4. There are 1743 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 3815 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KMT2CNM_170606.3 linkc.1365A>G p.Ile455Met missense_variant Exon 10 of 59 ENST00000262189.11 NP_733751.2 Q8NEZ4-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KMT2CENST00000262189.11 linkc.1365A>G p.Ile455Met missense_variant Exon 10 of 59 1 NM_170606.3 ENSP00000262189.6 Q8NEZ4-1

Frequencies

GnomAD3 genomes
AF:
0.0251
AC:
3817
AN:
152206
Hom.:
77
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00704
Gnomad AMI
AF:
0.0439
Gnomad AMR
AF:
0.0218
Gnomad ASJ
AF:
0.0167
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00600
Gnomad FIN
AF:
0.0268
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0401
Gnomad OTH
AF:
0.0239
GnomAD2 exomes
AF:
0.0238
AC:
5971
AN:
250670
AF XY:
0.0241
show subpopulations
Gnomad AFR exome
AF:
0.00640
Gnomad AMR exome
AF:
0.0170
Gnomad ASJ exome
AF:
0.0176
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0239
Gnomad NFE exome
AF:
0.0374
Gnomad OTH exome
AF:
0.0259
GnomAD4 exome
AF:
0.0368
AC:
53792
AN:
1460872
Hom.:
1167
Cov.:
30
AF XY:
0.0358
AC XY:
26049
AN XY:
726778
show subpopulations
African (AFR)
AF:
0.00598
AC:
200
AN:
33464
American (AMR)
AF:
0.0172
AC:
767
AN:
44692
Ashkenazi Jewish (ASJ)
AF:
0.0175
AC:
458
AN:
26130
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39640
South Asian (SAS)
AF:
0.00589
AC:
508
AN:
86228
European-Finnish (FIN)
AF:
0.0245
AC:
1310
AN:
53366
Middle Eastern (MID)
AF:
0.0104
AC:
60
AN:
5764
European-Non Finnish (NFE)
AF:
0.0438
AC:
48689
AN:
1111224
Other (OTH)
AF:
0.0298
AC:
1800
AN:
60364
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
2351
4702
7052
9403
11754
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1858
3716
5574
7432
9290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0250
AC:
3815
AN:
152324
Hom.:
77
Cov.:
32
AF XY:
0.0234
AC XY:
1743
AN XY:
74492
show subpopulations
African (AFR)
AF:
0.00702
AC:
292
AN:
41590
American (AMR)
AF:
0.0218
AC:
334
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.0167
AC:
58
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00601
AC:
29
AN:
4828
European-Finnish (FIN)
AF:
0.0268
AC:
284
AN:
10612
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.0401
AC:
2726
AN:
68018
Other (OTH)
AF:
0.0237
AC:
50
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
188
376
565
753
941
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
54
108
162
216
270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0344
Hom.:
349
Bravo
AF:
0.0241
TwinsUK
AF:
0.0467
AC:
173
ALSPAC
AF:
0.0488
AC:
188
ESP6500AA
AF:
0.00817
AC:
36
ESP6500EA
AF:
0.0434
AC:
373
ExAC
AF:
0.0230
AC:
2790
Asia WGS
AF:
0.00318
AC:
11
AN:
3478
EpiCase
AF:
0.0361
EpiControl
AF:
0.0382

ClinVar

Significance: Benign
Submissions summary: Benign:3Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1Other:1
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.43
T
BayesDel_noAF
Benign
-0.35
CADD
Benign
14
DANN
Benign
0.77
DEOGEN2
Benign
0.095
T;T
Eigen
Benign
-0.73
Eigen_PC
Benign
-0.63
FATHMM_MKL
Benign
0.53
D
LIST_S2
Benign
0.85
.;T
MetaRNN
Benign
0.0063
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.35
N;N
PhyloP100
-0.077
PrimateAI
Benign
0.35
T
PROVEAN
Benign
-0.89
N;N
REVEL
Benign
0.20
Sift
Benign
0.15
T;T
Polyphen
0.0040
B;B
Vest4
0.17
MPC
0.039
ClinPred
0.0034
T
GERP RS
-5.2
PromoterAI
0.0070
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.060
gMVP
0.17
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs77652527; hg19: chr7-151949735; COSMIC: COSV104384013; COSMIC: COSV104384013; API